Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ssCART-19 in Relapsed or Refractory B-ALL
NCT06367114Phase 2Not yet recruiting
- Sponsor
- Shanghai Unicar-Therapy Bio-medicine Technology Co., Ltd.
- Start
- Apr 2024
- Primary completion
- Sep 2024
- Modality
- CAR-T Cells
- Countries
- 1
01
Overview
A Phase 2 trial of ssCART-19 in B cell acute lymphoblastic leukemia (B-ALL), sponsored by Shanghai Unicar-Therapy Bio-medicine Technology Co., Ltd.. Planned start Apr 2024; status: not yet recruiting.
02
Drugs
ssCART-19
03
Conditions
B cell acute lymphoblastic leukemia (B-ALL)
Beyond the preview
Go deeper on NCT06367114.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06367114.